FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Sepantronium Bromide, 781661-94-7, Sepantronium Bromide Intermediate 22272-22-6, stock 519.5g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply.
Sepantronium Bromide, 781661-94-7, Sepantronium Bromide Intermediate 354824-10-5, stock 562.3g, white powder, assay by HPLC 99%, HNMR, LCMS we supply.
Sepantronium Bromide, 781661-94-7, Sepantronium Bromide Intermediate 20010-99-5, stock 206.3g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply.
Sepantronium Bromide, 781661-94-7, Sepantronium Bromide Intermediate 355405-02-6, stock 780.1g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply.
Sepantronium Bromide, 781661-94-7, Sepantronium Bromide Intermediate 781661-94-7, stock 425.8g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply.
